| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. | Director | Common Stock | 75.1K | $366K | $4.88 | Jun 20, 2024 | Direct |
| LISATA THERAPEUTICS, INC. | Director | Common Stock | 49.4K | $148K | $2.99 | Jan 9, 2024 | Direct |
| Aquestive Therapeutics, Inc. | Director | Stock Option (Right to Purchase) | 38K | Jun 20, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
| LSTA | LISATA THERAPEUTICS, INC. | Jan 9, 2024 | 1 | $0 | 4 | Jan 11, 2024 | Director |
| AQST | Aquestive Therapeutics, Inc. | Jun 21, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
| LSTA | LISATA THERAPEUTICS, INC. | Jan 9, 2023 | 1 | $0 | 4 | Jan 11, 2023 | Director |
| AQST | Aquestive Therapeutics, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
| LSTA | CALADRIUS BIOSCIENCES, INC. | Jan 10, 2022 | 1 | $0 | 4 | Jan 12, 2022 | Director |
| AQST | Aquestive Therapeutics, Inc. | Jun 15, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |